AbbVie

Open: 154.74 Close: 154.04 Change: -0.7

What an AI can tell you about AbbVie Stock before investing.

This document will help you to evaluate AbbVie without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Inc, Cerevel, Therapeutics, deal, Ronald, strong, and the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie Inc. is a pharmaceutical firm with a strong exposure to immunology and oncology. The company announced today that adult patients with relapsed/refractory (R/R) follicular lymphoma (FL) previously treated with two or more prior therapies experienced strong and durable responses.

Today's News

AbbVie Inc. is a pharmaceutical firm with a strong exposure to immunology and oncology. The company announced today that adult patients with relapsed/refractory (R/R) follicular lymphoma (FL) previously treated with two or more prior therapies experienced strong and durable responses. AbbVie Inc. announced the acquisition of Cerevel Therapeutics in a transformative move to strengthen our #neuroscience pipeline, with the goal of bringing new medicines to #patients with #neurgy and #psychiatric conditions. AbbVie Inc. (NYSE:ABBV) institutional investors after losing 0.1% over the previous year Key Insights Significantly high institutional ownership implies Abbvies stock price is sensitive to their trading. AbbV to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7B. The company to focus on smaller deals after buying spree. AbbVie Inc (ABBV) stock has gained 0.48% while the S&P 500 is higher by 0.07% as of 12:19 PM on Wednesday, Dec 13. The Analyst, R&D Operations Procure-to-Pay Support. AbbVie Inc. per Employee $1.103M P/E Ratio 42.16 EPS $3.65 Yield 4.02% Dividend $1.55 Ex-Dividend date Jan 12, 2024 Short Interest 11.13M 11/30/23. AbbVie Inc (NYSE: ABBV) said it will buy Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) for $8.7 billion in an all-cash deal. Cerevel options trading surge before deal raises eyebrows. AbbVie donated $40 million to North Chicago schools, Communities in Schools and Ronald McDonald houses. $100 million grant to Ronald McDonald House Charities added 670 guest sleeping rooms at 31 Ronald McDonalds houses across the United States.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

The game is changing. There is a new strategy to evaluate AbbVie fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Inc, Cerevel, Therapeutics, deal, Ronald, strong, and the most common words in the summary are: abbvie, stock, job, market, new, open, news, . One of the sentences in the summary was: The company announced today that adult patients with relapsed/refractory (R/R) follicular lymphoma (FL) previously treated with two or more prior therapies experienced strong and durable responses.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #job #market #new #open #news.